GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: BRX-220 | BRX220 | Miplyffa®
arimoclomol is an approved drug (FDA (2024))
Compound class:
Synthetic organic
Comment: Arimoclomol is an oral therapeutic candidate for the treatment of amyotrophic lateral sclerosis (ALS). Arimoclomol may be delivered as the citrate salt (BRX-345 with PubChem CID 72710735)
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. US FDA (2024) |
IUPAC Name ![]() |
| N-[(2R)-2-hydroxy-3-piperidin-1-ylpropoxy]-1-oxidopyridin-1-ium-3-carboximidoyl chloride |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8300 | arimoclomol |
Synonyms ![]() |
| BRX-220 | BRX220 | Miplyffa® |
Database Links ![]() |
|
| CAS Registry No. | 289893-25-0 |
| ChEMBL Ligand | CHEMBL2107726 |
| GtoPdb PubChem SID | 252166483 |
| PubChem CID | 9568077 |
| Search Google for chemical match using the InChIKey | SGEIEGAXKLMUIZ-XUVDNFPMSA-N |
| Search Google for chemicals with the same backbone | SGEIEGAXKLMUIZ |
| Search PubMed clinical trials | arimoclomol |
| Search PubMed titles | arimoclomol |
| Search PubMed titles/abstracts | arimoclomol |
| UniChem Compound Search for chemical match using the InChIKey | SGEIEGAXKLMUIZ-XUVDNFPMSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | SGEIEGAXKLMUIZ-XUVDNFPMSA-N |
| Wikipedia | Arimoclomol |